- Alterations of gyrA, gyrB, and parC and Activity of Efflux Pump in Fluoroquinolone-resistant Acinetobacter baumannii
-
Sunok Park, Kyeong Min Lee, Yong Sun Yoo, Jung Sik Yoo, Jae Il Yoo, Hwa Su Kim, Yeong Seon Lee, Gyung Tae Chung
-
Osong Public Health Res Perspect. 2011;2(3):164-170. Published online December 31, 2011
-
DOI: https://doi.org/10.1016/j.phrp.2011.11.040
-
-
3,566
View
-
19
Download
-
37
Crossref
-
Abstract
PDF
- Objectives
This study investigated the fluoroquinolone-resistant mechanism of 56 clinical cases of A baumannii infection from 23 non-tertiary hospitals, collected between 2004 and 2006. Methods
Susceptibility testing was performed by broth microdilution and Epsilometer test. Analyses of quinolone resistance-determining region (QRDR) were done by sequencing. The activity of the efflux pump was measured using inhibitors. Results
The sequences from selected 56 isolates were divided into seven groups (I-VII) on the basis of mutations in gyrA (S83L), parC (S80L, S80W and S84K) and gyrB (containing the novel mutations E679D, D644Y and A677V). The 27 isolates with triple mutations in gyrA, gyrB and parC (groups IV-VII) showed higher levels of resistance to ciprofloxacin (minimal inhibitory concentration [MIC] of 16-256 μg/mL) than the 26 isolates with double mutations in gyrA and parC (groups II and III, MIC of 8-64 μ g/mL; p < 0.05). Alterations in the efflux pump were observed in four isolates with the parC S80L mutation (group II) or E84K mutation (group VII), but no effect was observed in an isolate with the parC S80 W mutation (group III). Conclusion
These results suggest that triple mutations in clinical isolates of A baumannii contribute to the development of high levels of resistance to fluoroquinolones and that mutations in parC S80L or E84K (groups II and VII) may contribute to alterations in efflux pump activity in A baumannii.
-
Citations
Citations to this article as recorded by
- Types and Mechanisms of Efflux Pump Systems and the Potential of Efflux Pump Inhibitors in the Restoration of Antimicrobial Susceptibility, with a Special Reference to Acinetobacter baumannii
Kira M. Zack, Trent Sorenson, Suresh G. Joshi Pathogens.2024; 13(3): 197. CrossRef - Association Between Drug Efflux Pumps and Resistance to Ciprofloxacin in Clinical Isolates of Acinetobacter baumannii
Nour Amirmozafari, Azam Haddadi, Reza Mirnejad, Seyed Abdolhamid Angaji, Ebrahim Babapour Iranian Journal of Medical Microbiology.2024; 18(2): 113. CrossRef - Antimicrobial resistance genes harbored in invasive Acinetobacter calcoaceticus-baumannii complex isolated from Korean children during the pre-COVID-19 pandemic periods, 2015–2020
Hyun Mi Kang, Kyung Ran Kim, Gahee Kim, Dong-gun Lee, Yae Jean Kim, Eun Hwa Choi, Jina Lee, Ki Wook Yun Frontiers in Cellular and Infection Microbiology.2024;[Epub] CrossRef - Navigating fluoroquinolone resistance in Gram-negative bacteria: a comprehensive evaluation
Linda Kherroubi, Joanna Bacon, Khondaker Miraz Rahman JAC-Antimicrobial Resistance.2024;[Epub] CrossRef - Development of Nanoparticle Adaptation Phenomena in Acinetobacter baumannii: Physiological Change and Defense Response
Oliver McNeilly, Riti Mann, Max Laurence Cummins, Steven P. Djordjevic, Mehrad Hamidian, Cindy Gunawan, Victor Gonzalez Microbiology Spectrum.2023;[Epub] CrossRef - Colistin potentiation in multidrug-resistant Acinetobacter baumannii by a non-cytotoxic guanidine derivative of silver
Deepak Kumar, Chaitali Singhal, Manisha Yadav, Pooja Joshi, Priyanka Patra, Subhash Tanwar, Amitava Das, Sumit Kumar Pramanik, Susmita Chaudhuri Frontiers in Microbiology.2023;[Epub] CrossRef - Phenotypic and Molecular Characteristics of Carbapenem-Resistant Acinetobacter baumannii Isolates from Bulgarian Intensive Care Unit Patients
Tanya V. Strateva, Ivo Sirakov, Temenuga J. Stoeva, Alexander Stratev, Slavil Peykov Microorganisms.2023; 11(4): 875. CrossRef - Effect of Phenylalanine–Arginine Beta-Naphthylamide on the Values of Minimum Inhibitory Concentration of Quinolones and Aminoglycosides in Clinical Isolates of Acinetobacter baumannii
Stefany Plasencia-Rebata, Saul Levy-Blitchtein, Juana del Valle-Mendoza, Wilmer Silva-Caso, Isaac Peña-Tuesta, William Vicente Taboada, Fernando Barreda Bolaños, Miguel Angel Aguilar-Luis Antibiotics.2023; 12(6): 1071. CrossRef - How to treat severe Acinetobacter baumannii infections
Emilio Bouza, Patricia Muñoz, Almudena Burillo Current Opinion in Infectious Diseases.2023; 36(6): 596. CrossRef - Comparative genotypic characterization related to antibiotic resistance phenotypes of clinical carbapenem-resistant Acinetobacter baumannii MTC1106 (ST2) and MTC0619 (ST25)
Made Rai Dwitya Wiradiputra, Krit Thirapanmethee, Piyatip Khuntayaporn, Pagakrong Wanapaisan, Mullika Traidej Chomnawang BMC Genomics.2023;[Epub] CrossRef - A comprehensive review on potential therapeutic inhibitors of nosocomial Acinetobacter baumannii superbugs
Danaboina Srikanth, Swanand Vinayak Joshi, Mahammad Ghouse Shaik, Gaurav Pawar, Sushmitha Bujji, Vinaykumar Kanchupalli, Sidharth Chopra, Srinivas Nanduri Bioorganic Chemistry.2022; 124: 105849. CrossRef - Differential Binding of Carbapenems with the AdeABC Efflux Pump and Modulation of the Expression of AdeB Linked to Novel Mutations within Two-Component System AdeRS in Carbapenem-Resistant Acinetobacter baumannii
Subhasree Roy, Vivek Junghare, Shanta Dutta, Saugata Hazra, Sulagna Basu, Christopher W. Marshall mSystems.2022;[Epub] CrossRef - Antimicrobial Resistance, Integron Carriage, and Fluoroquinolone Resistance Genes in Acinetobacte baumannii Isolates
Parastoo Ashouri, Jafar Mohammadshahi, Vajihe Sadat Nikbin, Hadi Peeridogaheh, Behnam Mohammadi-Ghalehbin, Soheila Refahi, Amir Teimourpour, Majid Esmaelizad, Hafez Mirzaneghad, Roghayeh Teimourpour Archives of Clinical Infectious Diseases.2022;[Epub] CrossRef - Efflux pumps in multidrug-resistant Acinetobacter baumannii: Current status and challenges in the discovery of efflux pumps inhibitors
Privita Verma, Monalisa Tiwari, Vishvanath Tiwari Microbial Pathogenesis.2021; 152: 104766. CrossRef - Overexpression of Efflux Pumps, Mutations in the Pumps’ Regulators, Chromosomal Mutations, and AAC(6′)-Ib-cr Are Associated With Fluoroquinolone Resistance in Diverse Sequence Types of Neonatal Septicaemic Acinetobacter baumannii: A 7-Year Single Center S
Subhasree Roy, Somdatta Chatterjee, Amrita Bhattacharjee, Pinaki Chattopadhyay, Bijan Saha, Shanta Dutta, Sulagna Basu Frontiers in Microbiology.2021;[Epub] CrossRef - Shared and Unique Evolutionary Trajectories to Ciprofloxacin Resistance in Gram-Negative Bacterial Pathogens
Jaime E. Zlamal, Semen A. Leyn, Mallika Iyer, Marinela L. Elane, Nicholas A. Wong, James W. Wamsley, Maarten Vercruysse, Fernando Garcia-Alcalde, Andrei L. Osterman, Igor B. Zhulin mBio.2021;[Epub] CrossRef - Efflux Pump Activity and Mutations Driving Multidrug Resistance in Acinetobacter baumannii at a Tertiary Hospital in Pretoria, South Africa
Noel-David Nogbou, Granny M. Nkawane, Khanyisa Ntshane, Charles K. Wairuri, Dikwata T. Phofa, Kagiso K. Mokgokong, Mbudzeni Ramashia, Maphoshane Nchabeleng, Lawrence C. Obi, Andrew M. Musyoki, Todd R. Callaway International Journal of Microbiology.2021; 2021: 1. CrossRef - The effect of the efflux pump inhibitor Carbonyl Cyanide m-Chlorophenylhydrazone (CCCP) on the susceptibility to imipenem and cefepime in clinical strains of Acinetobacter baumannii
Alejandra Sanchez-Carbonel, Belén Mondragón, Nicolás López-Chegne, Isaac Peña-Tuesta, Gladys Huayan-Dávila, Dora Blitchtein, Hugo Carrillo-Ng, Wilmer Silva-Caso, Miguel Angel Aguilar-Luis, Juana del Valle-Mendoza, Iddya Karunasagar PLOS ONE.2021; 16(12): e0259915. CrossRef - Effects of different resistance mechanisms on antimicrobial resistance in Acinetobacter baumannii: a strategic system for screening and activity testing of new antibiotics
Yu-Kuo Tsai, Ci-Hong Liou, Jung-Chung Lin, Chang-Phone Fung, Feng-Yee Chang, L. Kristopher Siu International Journal of Antimicrobial Agents.2020; 55(4): 105918. CrossRef - Antibiotic Resistance Profiles, Molecular Mechanisms and Innovative Treatment Strategies of Acinetobacter baumannii
Corneliu Ovidiu Vrancianu, Irina Gheorghe, Ilda Barbu Czobor, Mariana Carmen Chifiriuc Microorganisms.2020; 8(6): 935. CrossRef - Bacterial Genome Wide Association Studies (bGWAS) and Transcriptomics Identifies Cryptic Antimicrobial Resistance Mechanisms in Acinetobacter baumannii
Chandler Roe, Charles H. D. Williamson, Adam J. Vazquez, Kristen Kyger, Michael Valentine, Jolene R. Bowers, Paul D. Phillips, Veronica Harrison, Elizabeth Driebe, David M. Engelthaler, Jason W. Sahl Frontiers in Public Health.2020;[Epub] CrossRef - Molecular Analyses of Biofilm-Producing Clinical Acinetobacter baumannii Isolates from a South Indian Tertiary Care Hospital
Balaram Khamari, Manmath Lama, Chanakya Pachi Pulusu, Amarendra Pratap Biswal, Sai Manoz Lingamallu, Bhargava Sai Mukkirla, Amit Kumar Sahoo, Harioum Sambhu Narayan Dash, Rewa Sharda, Prakash Kumar, Eswarappa Pradeep Bulagonda Medical Principles and Practice.2020; 29(6): 580. CrossRef - Using WGS to identify antibiotic resistance genes and predict antimicrobial resistance phenotypes in MDR Acinetobacter baumannii in Tanzania
Happiness H Kumburu, Tolbert Sonda, Marco van Zwetselaar, Pimlapas Leekitcharoenphon, Oksana Lukjancenko, Blandina T Mmbaga, Michael Alifrangis, Ole Lund, Frank M Aarestrup, Gibson S Kibiki Journal of Antimicrobial Chemotherapy.2019; 74(6): 1484. CrossRef - Phenotypic and Genotypic Characterization of Acinetobacter spp. Panel Strains: A Cornerstone to Facilitate Antimicrobial Development
Roshan D'Souza, Naina A. Pinto, Nguyen Le Phuong, Paul G. Higgins, Thao Nguyen Vu, Jung-Hyun Byun, Young Lag Cho, Jong Rak Choi, Dongeun Yong Frontiers in Microbiology.2019;[Epub] CrossRef - Multidrug Resistant Acinetobacter baumannii: Resistance by Any Other Name Would Still be Hard to Treat
David A. Butler, Mark Biagi, Xing Tan, Samah Qasmieh, Zackery P. Bulman, Eric Wenzler Current Infectious Disease Reports.2019;[Epub] CrossRef - Molecular Study of Quinolone Resistance Determining Regions of gyrA Gene and parC Genes in Clinical Isolates of Acintobacter baumannii Resistant to Fluoroquinolone
Maysaa El Sayed Zaki, Nermen Abou ElKheir, Mohamed Mofreh The Open Microbiology Journal.2018; 12(1): 116. CrossRef - Species distribution, virulence factors and antimicrobial resistance of Acinetobacter spp. isolates from dogs and cats: a preliminary study
Yui Kimura, Kazuki Harada, Takae Shimizu, Tomomi Sato, Akari Kajino, Masaru Usui, Yutaka Tamura, Yuzo Tsuyuki, Tadashi Miyamoto, Asami Ohki, Masahisa Watarai Microbiology and Immunology.2018; 62(7): 462. CrossRef - Multiple mechanisms contributing to ciprofloxacin resistance among Gram negative bacteria causing infections to cancer patients
Samira M. Hamed, Walid F. Elkhatib, Hadir A. El-Mahallawy, Mai M. Helmy, Mohamed S. Ashour, Khaled M. A. Aboshanab Scientific Reports.2018;[Epub] CrossRef - Synthesis and investigation of binding interactions of 1,4-benzoxazine derivatives on topoisomerase IV in Acinetobacter baumannii
S. Yilmaz, I. Yalcin, S. Okten, F. K. Onurdag, E. Aki-Yalcin SAR and QSAR in Environmental Research.2017; 28(11): 941. CrossRef - Antibacterial Resistance in Ureaplasma Species and Mycoplasma hominis Isolates from Urine Cultures in College-Aged Females
Marissa A. Valentine-King, Mary B. Brown Antimicrobial Agents and Chemotherapy.2017;[Epub] CrossRef - MOLECULAR BACKGROUND OF FLUOROQUINOLONE RESISTANCE IN PATHOGENIC HUMAN MYCOPLASMAS
A. N. Vaganova Russian Journal of Infection and Immunity.2017; 7(3): 231. CrossRef - Alarmingly High Segregation Frequencies of Quinolone Resistance Alleles within Human and Animal Microbiomes Are Not Explained by Direct Clinical Antibiotic Exposure
Wesley Field, Ruth Hershberg Genome Biology and Evolution.2015; 7(6): 1743. CrossRef - Multidrug-resistant Acinetobactor baumannii isolated from a traveler returned from Brunei
Masayoshi Tojo, Momoko Mawatari, Kayoko Hayakawa, Maki Nagamatsu, Kayo Shimada, Kazuhisa Mezaki, Yuko Sugiki, Emi Kuroda, Nozomi Takeshita, Satoshi Kutsuna, Yoshihiro Fujiya, Tohru Miyoshi-Akiyama, Teruo Kirikae, Norio Ohmagari Journal of Infection and Chemotherapy.2015; 21(3): 212. CrossRef - Correlation of Ciprofloxacin Resistance with the AdeABC Efflux System in Acinetobacter baumannii Clinical Isolates
Abdollah Ardebili, Abdolaziz Rastegar Lari, Malihe Talebi Annals of Laboratory Medicine.2014; 34(6): 433. CrossRef - Effect of Efflux Pump Inhibitor Carbonyl Cyanide 3-Chlorophenylhydrazone on the Minimum Inhibitory Concentration of Ciprofloxacin in Acinetobacter baumannii Clinical Isolates
Abdollah Ardebili, Malihe Talebi, Leila Azimi, Abdolaziz Rastegar Lari Jundishapur Journal of Microbiology.2014;[Epub] CrossRef - Characterization of Acinetobacter baumannii Clinical Isolates Carrying blaOXA-23 Carbapenemase and 16S rRNA Methylase armA genes in Yemen
Sofiane Bakour, Samer Ahmed Alsharapy, Abdelaziz Touati, Jean-Marc Rolain Microbial Drug Resistance.2014; 20(6): 604. CrossRef - First report of 16S rRNA methylase ArmA-producing Acinetobacter baumannii and rapid spread of metallo-β-lactamase NDM-1 in Algerian hospitals
Sofiane Bakour, Abdelaziz Touati, Taous Bachiri, Farida Sahli, Djamel Tiouit, Malek Naim, Mounia Azouaou, Jean-Marc Rolain Journal of Infection and Chemotherapy.2014; 20(11): 696. CrossRef
|